hepatitischope.blogspot.com
Hepatitis C Hope: Clinical Trials for Natural Hepatitis C Remedy Looking Good
http://hepatitischope.blogspot.com/2006/07/clinical-trials-for-natural-hepatitis.html
Wednesday, July 05, 2006. Clinical Trials for Natural Hepatitis C Remedy Looking Good. June 28, 2006. What can interferon non-responders do about Hepatitis c? What about people who cannot or will not tolerate the devastating side effects of interferon therapy? Find out about the positive preliminary results from a medical study of a natural Japanese prescription medicine that's available to patients now. Posted by Joyfulstill @ 5:33 PM. Comments: Post a Comment. Links to this post:. Martin's Hep C Site.
hepatitischope.blogspot.com
Hepatitis C Hope: Definition of HCV PCR
http://hepatitischope.blogspot.com/2006/06/definition-of-hcv-pcr.html
Tuesday, June 06, 2006. Definition of HCV PCR. HCV PCR: HCV PCR (polymerase chain reaction) is a test for the hepatitis C virus (HCV). There are three types of HCV PCR tests:. The HCV PCR viral detection test: This qualitative test is designed to detect whether the hepatitis C virus is or is not present. The HCV PCR viral load test: This quantitative test looks for the virus and estimates the number of HCV viruses per ml of blood. Posted by Joyfulstill @ 9:44 PM. Comments: Post a Comment.
hcvnews.blogspot.com
HCV News - The Hepatitis C Blog
http://hcvnews.blogspot.com/2009_11_01_archive.html
HCV News : :. November 01, 2009. Twice Daily Dosing Of Vertex Hep C Drug Works Well. Vertex Pharmaceuticals Inc's closely watched hepatitis C drug telaprevir proved nearly equally effective in a twice daily regimen as three times a day, knocking out the virus in more than 80 percent of patients in both groups in a small study. SVR rates of 75 to 80 percent (in twice daily dosing) would be very well received by investors," Sanford Bernstein analyst Geoffrey Porges said prior to release of the data. I was ...
hcvnews.blogspot.com
HCV News - The Hepatitis C Blog
http://hcvnews.blogspot.com/2007_07_01_archive.html
HCV News : :. July 11, 2007. Woman tries unusual drug for hepatitis. Might be one of the few people in the country to cure herself of hepatitis C, a virus-caused inflammatory liver condition, using a drug designed to treat Parkinson's disease. Other sources could be sexual contact if there are open sores on both partners, tattoos or from sharing a razor or a toothbrush with an infected person whose gums or skin are bleeding. There is no vaccine, although people at risk are advised to be vaccinated fo...
hcvnews.blogspot.com
HCV News - The Hepatitis C Blog
http://hcvnews.blogspot.com/2007_05_01_archive.html
HCV News : :. May 23, 2007. Hepatitis C: Efficient Treatment Developed. Havana, May 21 (Prensa Latina) Cuban biotechnology took a new and very important step in obtaining an efficient treatment for Hepatitis C, a disease that affects about 200 million persons in the world. It is produced by the Heberbiotec factory in Cuba that is in charge of commercialization of its biotechnological products. Heberviron successfully attacks the virus in circulation, according to tests made in the National Institute of G...
hcvnews.blogspot.com
HCV News - The Hepatitis C Blog
http://hcvnews.blogspot.com/2009/11/vertex-hep-c-drug-improves-cure-rates.html
HCV News : :. November 01, 2009. Vertex Hep C Drug Improves Cure Rates. Vertex Pharmaceuticals released additional clinical data Wednesday demonstrating the potential for its experimental hepatitis C drug telaprevir to significantly improve the cure rates in patients who failed prior treatment. The new data released Wednesday, therefore, appear to bolster Vertex's claim that telaprevir can improve the cure rate for even the most difficult-to-treat patients - those who don't respond to standard hepatitis ...
hcvnews.blogspot.com
HCV News - The Hepatitis C Blog
http://hcvnews.blogspot.com/2006_10_01_archive.html
HCV News : :. October 10, 2006. Vertex: A Promising Hep-C Play. Says the pharma company's VX-950 could not only become part of a new standard hepatitis C treatment, but also alter the treatment "paradigm". In our opinion, investor confidence would be boosted should forthcoming data remain positive. In turn, we think the share price would move higher. The stock carries Standard and Poor's highest investment recommendation, 5 STARS (strong buy). Vertex is a biotech company and, therefore, carri...Vertex's ...
hcvnews.blogspot.com
HCV News - The Hepatitis C Blog
http://hcvnews.blogspot.com/2007_10_01_archive.html
HCV News : :. October 02, 2007. According to a Reuters report,. A closely watched hepatitis C drug being developed by Vertex Pharmaceuticals Inc continues to promise improvement over current treatments, according to analysts who have viewed brief summaries of data from highly anticipated clinical trials. Other analysts also said the available data appears to add up to an SVR of at least 70 percent in the clinical trial known as PROVE-2. An SVR rate higher than 50 percent is considered to be positive ...
